Benitec Biopharma (BNTC) Earnings Date, Estimates & Call Transcripts $12.56 -0.15 (-1.18%) Closing price 08/19/2025 04:00 PM EasternExtended Trading$12.55 -0.01 (-0.08%) As of 08/19/2025 04:25 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Benitec Biopharma Earnings Summary Benitec Biopharma posted Q3 2025 earnings on May 14, 2025, reporting an EPS of -$0.24, which topped the consensus estimate of -$0.36 by $0.12. With a trailing EPS of -$1.51, Benitec Biopharma's earnings are expected to decrease next year, from ($1.48) to ($2.31) per share. Upcoming Q4 Earnings DateSep. 25EstimatedConsensus EPS (May. 14) -$0.36 Actual EPS (May. 14) -$0.24 Beat By $0.12 Q3 2025 Earnings ResourcesQ3 2025 Earnings Report Press Release (8-K) Quarterly Report (10-Q)BNTC Upcoming EarningsBenitec Biopharma's next earnings date is estimated for Thursday, September 25, 2025, based on past reporting schedules. Powered by Get Benitec Biopharma Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Benitec Biopharma and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataBNTC Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.BNTC Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Benitec Biopharma Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$0.54-$0.54-$0.54Q2 20252-$0.34-$0.27-$0.31Q3 20252-$0.31-$0.26-$0.29Q4 20252-$0.26-$0.25-$0.26 Benitec Biopharma Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 9/25/2025(Estimated)--------5/14/2025Q3 2025-$0.36-$0.24+$0.12-$0.24--2/14/2025Q2 2025-$0.55-$0.36+$0.19-$0.33--5/13/2024Q3 2024--$1.64--$1.64--2/13/2024Q2 2024--$2.64--$2.64--11/13/2023Q1 2024--$2.76--$2.76-- Benitec Biopharma Earnings - Frequently Asked Questions When is Benitec Biopharma's earnings date? Benitec Biopharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, September 25th, 2025 based off last year's report dates. Learn more on BNTC's earnings history. Did Benitec Biopharma beat their earnings estimates last quarter? In the previous quarter, Benitec Biopharma (NASDAQ:BNTC) reported ($0.24) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.36) by $0.12. Learn more on analysts' earnings estimate vs. BNTC's actual earnings. How much revenue does Benitec Biopharma generate each year? Benitec Biopharma (NASDAQ:BNTC) has a recorded annual revenue of $80,000.00. How much profit does Benitec Biopharma generate each year? Benitec Biopharma (NASDAQ:BNTC) has a recorded net income of -$21.75 million. BNTC has generated -$1.51 earnings per share over the last four quarters. What is Benitec Biopharma's EPS forecast for next year? Benitec Biopharma's earnings are expected to decrease from ($1.48) per share to ($2.31) per share in the next year. More Earnings Resources from MarketBeat Related Companies AVDL Earnings CVAC Earnings PAHC Earnings NTLA Earnings XERS Earnings COLL Earnings SNDX Earnings PHVS Earnings VERV Earnings LENZ Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles DLocal Stock Soars 43% After Earnings Beat and Raised GuidanceGreen Dot's 30% Rally: Turnaround Takes Off on Explosive EarningsElbit Systems Jumps on Record Earnings and a $1.6B ContractBrinker Serves Up Earnings Beat, Sidesteps Cost PressuresWhy BigBear.ai Stock's Dip on Earnings Can Be an Opportunity CrowdStrike Faces Valuation Test Before Key Earnings ReportPost-Earnings, How Does D-Wave Stack Up Against Quantum Rivals? This page (NASDAQ:BNTC) was last updated on 8/20/2025 by MarketBeat.com Staff From Our PartnersWinning the AI WarWhat’s really driving the trade wars, reshoring, and sweeping executive orders? According to Porter Stansberry...Porter & Company | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredNational 'Stock Market Reset' Coming September 30 (New WH Order)Crash Coming Sept 30? Analysts Warn of New Crisis A new problem on the U.S. power grid is putting millions ...Altimetry | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredElon Musk’s New TechnologyElon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a n...Paradigm Press | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Benitec Biopharma Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Benitec Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access